1.Pomeranz LE, Reynolds AE, Hengartner CJ. Molecular biology of pseudorabies virus: impact on neurovirology and veterinary medicine. 2005;69(3):462.
2.Mettenleiter TC. Molecular biology of pseudorabies (Aujeszky’s disease) virus. 1991;14(2):151–63.
3.Masot AJ, Gil M, Risco D, Jiménez OM, Nú?ez JI, Redondo E. Pseudorabies virus infection (Aujeszky’s disease) in an Iberian lynx (Lynx pardinus) in Spain: a case report. BMC Vet Res.13(1):6.
4.Boadella M, Gortázar C, Vicente J, Ruiz-Fons F. Wild boar: An increasing concern for Aujeszky’s disease control in pigs? BMC Vet Res. 2012;8(1):7.
5.Klupp BG, Hengartner CJ, Mettenleiter TC, Enquist LW. Complete, Annotated Sequence of the Pseudorabies Virus Genome. J Virol. 2004;78(1):424–40.
6.Luo Y, Li N, Cong X, Wang C-H, Du M, Li L, et al. Pathogenicity and genomic characterization of a pseudorabies virus variant isolated from Bartha-K61-vaccinated swine population in China. Vet Microbiol.174(1–2):107–15.
7.童光志, 陈焕春. 伪狂犬病流行现状及我国应采取的防制措施%Epidemic present status and prophylactico-therapeutic measures of pseudorabies taken in China. 中国兽医学报.019(1):1–2.
8.Hahn EC, Fadl-Alla B, Lichtensteiger CA. Variation of Aujeszky’s disease viruses in wild swine in USA. Vet Microbiol. 2010;143(1):45–51.
9.Batza H, editor Eradication of Aujeszky’s disease in Germany. Proc International Conference on the Control of Infectious Animal Diseases by Vaccination; 2004.
10.MacDiarmid S. Aujeszky’s disease eradication in New Zealand. Aust Vet J. 2000;78(7):470–1.
11.An TQ, Peng JM, Tian ZJ, Zhao HY, Li N, Liu YM, et al. Pseudorabies Virus Variant in Bartha-K61—Vaccinated Pigs, China, 2012. Emerg Infect Dis. 2013;19(11):1749–55.
12.a SMS, a LJ. Dietary Flavonoid Sources in Australian Adults. Nutr Cancer.60(4):p.442–9.
13.Santos J, Monte A, Lins T, Barberino R, Menezes V, Gouveia B, et al. Kaempferol can be used as the single antioxidant in the in vitro culture medium, stimulating sheep secondary follicle development through the phosphatidylinositol 3-kinase signaling pathway. Theriogenology. 2019;136:86–94.
14.Imran M, Rauf A, Shah ZA, Saeed F, Imran A, Arshad MU, et al. Chemo-preventive and therapeutic effect of the dietary flavonoid kaempferol: A comprehensive review. Phytother Res.
15.Kampk?Tter A, Nkwonkam CG, Zurawski RF, Timpel C, Chovolou Y, W?tjen W, et al. Effects of the flavonoids kaempferol and fisetin on thermotolerance, oxidative stress and FoxO transcription factor DAF–16 in the model organismCaenorhabditis elegans.81(12):849–58.
16.Wang L, Tu Y-C, Lian T-W, Hung J-T, Yen J-H, Wu M-J. Distinctive Antioxidant and Antiinflammatory Effects of Flavonols. J Agric Food Chem.54(26):9798–804.
17.Min JP, Lee EK, Heo HS, Kim MS, Sung B, Mi KK, et al. The anti-inflammatory effect of kaempferol in aged kidney tissues: the involvement of nuclear factor-kappaB via nuclear factor-inducing kinase/IkappaB kinase and mitogen-activated protein kinase pathways. J Med Food. 2009;12(2):351–8.
18.Medeiros KCP, Faustino L, Borduchi E, Nascimento RJB, Silva TMS, Gomes E, et al. Preventive and curative glycoside kaempferol treatments attenuate the TH2-driven allergic airway disease.9(13–14):0–1548.
19.Lim YH, Kim IH, Seo JJ. In vitro Activity of Kaempferol Isolated from the Impatiens balsamina alone and in Combination with Erythromycin or Clindamycin against Propionibacterium acnes. 2007;45(5):1358.
20.Imran M, Salehi B, Sharifi-Rad J, Aslam Gondal T, Saeed F, Imran A, et al. Kaempferol: A key emphasis to its anticancer potential. Molecules. 2019;24(12):2277.
21.Lam T, Rotunno M, Randi G, Bagnardi V, Subar A, Landi MT. Intake of quercetin and isothiocyanates and risk of lung cancer: A population-based case-control study. 2008;68.
22.Gates MA, Tworoger SS, Hecht JL, Vivo ID, Rosner B, Hankinson SE. A prospective study of dietary flavonoid intake and incidence of epithelial ovarian cancer. Int J Cancer.121(10):2225–32.
23.Nöthlings U, Murphy SP, Wilkens LR, Henderson BE, Kolonel LN. Flavonols and Pancreatic Cancer Risk The Multiethnic Cohort Study. Am J Epidemiol. 2007;166(8):924–31.
24.Garcia-Closas R, Gonzalez CA, Agudo A, Riboli E. Intake of specific carotenoids and flavonoids and the risk of gastric cancer in Spain. Cancer Causes Control. 1999;10(1):71–5.
25.Zhang R, Ai X, Duan Y, Xue M, He W, Wang C, et al. Kaempferol ameliorates H9N2 swine influenza virus-induced acute lung injury by inactivation of TLR4/MyD88-mediated NF-κB and MAPK signaling pathways. Biomed Pharmacother. 2017;89:660–72.
26.Amoros M, Sim?s CMO, Girre L, Sauvager F, Cormier M. Synergistic Effect of Flavones and Flavonols Against Herpes Simplex Virus Type 1 in Cell Culture. Comparison with the Antiviral Activity of Propolis. J Nat Prod.55(12):1732–40.
27.Debiaggi M, Tateo F, Pagani L, Luini M, Romero E. Effects of propolis flavonoids on virus infectivity and replication. Microbiologica. 1990;13(3):207–13.
28.Min BS, Tomiyama M, Ma CM, Nakamura N, Hattori M. Kaempferol acetylrhamnosides from the rhizome of Dryopteris crassirhizoma and their inhibitory effects on three different activities of human immunodeficiency virus–1 reverse transcriptase. 2010;32(46):no-no.
29.Mahmood N, Piacente S, Pizza C, Burke A, Khan AI, Hay AJ. The Anti-HIV Activity and Mechanisms of Action of Pure Compounds Isolated fromRosa damascena.229(1):0–79.
30.Robin V, Irurzun A, Amoros M, Boustie J, Carrasco L. Antipoliovirus Flavonoids from Psiadia Dentata. Antivir Chem Chemother.12(5):283–91.
31.Ludwig S. Influenza viruses and MAP kinase cascades—Novel targets for an antiviral intervention? Signal Transduction.7(1):81–8.
32.Lee SM, Kleiboeker SB. Porcine arterivirus activates the NF-κB pathway through IκB degradation.342(1):47–59.
33.Novel pseudorabies virus variant with defects in TK,gE and gI protects growing pigs against lethal challenge. 中国畜牧兽医学会动物传染病学分会第十六次学术研讨会论文集; 2015.
34.Control of swine pseudorabies in China: Opportunities and limitations. Vet Microbiol.183:119–24.
35.Zhao X, Cui Q, Fu Q, Song X, Jia R, Yang Y, et al. Antiviral properties of resveratrol against pseudorabies virus are associated with the inhibition of IκB kinase activation. Sci Rep. 2017;7(1):1–11.
36.Mettenleiter TC. Initiation and spread of alpha-herpesvirus infections. Trends Microbiol. 1994;2(1):2.
37.Karger A, Mettenleiter TC. Glycoproteins gIII and gp50 Play Dominant Roles in the Biphasic Attachment of Pseudorabies Virus.194(2):654–64.
38.Cheung AK. DNA nucleotide sequence analysis of the immediate-early gene of pseudorabies virus. Nucleic Acids Res. 1989(12):12.
39.Xu J, Yin Z, Li L, Cheng A, Jia R, Song X, et al. Inhibitory effect of resveratrol against duck enteritis virus in vitro. PLoS One. 2013;8(6).
40.Mettenleiter TC. Aujeszky’s disease (pseudorabies) virus: the virus and molecular pathogenesis - State of the art, June 1999. 2000;31(1):99.
41.Elion GB. The biochemistry and mechanism of action of acyclovir. J Antimicrob Chemother. 1983(suppl_B):suppl_B.
42.Gao Z, Dou Y, Chen Y, Zheng Y. MicroRNA Roles in the NF-κB Signaling Pathway during Viral Infections. 2014;2014(1):436097.
43.Riteau, B. Trypsin increases pseudorabies virus production through activation of the ERK signalling pathway. J Gen Virol.87(5):1109–12.
44.Zika virus infection induces RNAi-mediated antiviral immunity in human neural progenitors and brain organoids.
45.Chang C-D, Lin P-Y, Liao M-H, Chang C-I, Hsu J-L, Yu F-L, et al. Suppression of apoptosis by pseudorabies virus Us3 protein kinase through the activation of PI3-K/Akt and NF-κB pathways. Res Vet Sci. 2013;95(2):764–74.
46.Sharma-Walia N, Krishnan HH, Naranatt PP, Zeng L, Smith MS, Chandran B. ERK1/2 and MEK1/2 induced by Kaposi’s sarcoma-associated herpesvirus (human herpesvirus 8) early during infection of target cells are essential for expression of viral genes and for establishment of infection. J Virol. 2005;79(16):10308–29.
47.Yeh C-J, Lin P-Y, Liao M-H, Liu H-J, Lee J-W, Chiu S-J, et al. TNF-α mediates pseudorabies virus-induced apoptosis via the activation of p38 MAPK and JNK/SAPK signaling. Virology. 2008;381(1):55–66.
48.Cheung A, Chen Z, Sun Z, McCullough D. Pseudorabies virus induces apoptosis in tissue culture cells. Arch Virol. 2000;145(10):2193–200.
49.Sun Y, Liu WZ, Liu T, Feng X, Zhou HF. Signaling pathway of MAPK/ERK in cell proliferation, differentiation, migration, senescence and apoptosis. J Recept Signal Transduct Res. 2015;35(6):1–5.
50.Goodkin ML, Ting AT, Blaho JA. NF-?B Is Required for Apoptosis Prevention during Herpes Simplex Virus Type 1 Infection. J Virol.77(13):7261–80.
51.Kido H. Influenza virus pathogenicity regulated by host cellular proteases, cytokines and metabolites, and its therapeutic options. Proceedings of the Japan Academy, Series B. 2015;91(8):351–68.
52.Mori N, Prager D. Transactivation of the interleukin–1alpha promoter by human T-cell leukemia virus type I and type II Tax proteins. 1996.
53.Hiscott J, Marois J, Garoufalis J, D’addario M, Roulston A, Kwan I, et al. Characterization of a functional NF-kappa B site in the human interleukin 1 beta promoter: evidence for a positive autoregulatory loop. Mol Cell Biol. 1993;13(10):6231–40.
54.Serfling E, Barthelmäs R, Pfeuffer I, Schenk B, Zarius S, Swoboda R, et al. Ubiquitous and lymphocyte‐specific factors are involved in the induction of the mouse interleukin 2 gene in T lymphocytes. The EMBO journal. 1989;8(2):465–73.
55.Hoyos B, Ballard DW, Bohnlein E, Siekevitz M, Greene WC. Kappa B-specific DNA binding proteins: role in the regulation of human interleukin–2 gene expression. Science. 1989;244(4903):457–60.
56.Adamson AL, Darr D, Holley-Guthrie E, Johnson RA, Mauser A, Swenson J, et al. Epstein-Barr Virus Immediate-Early Proteins BZLF1 and BRLF1 Activate the ATF2 Transcription Factor by Increasing the Levels of Phosphorylated p38 and c-Jun N-Terminal Kinases. J Virol.74(3):1224–33.
57.Meng Q, Xia Y. c-Jun, at the crossroad of the signaling network. Protein & Cell. 2011;2(11):889–98.
58.Salehi B, Martorell M, Arbiser JL, Sureda A, Martins N, Maurya PK, et al. Antioxidants: Positive or negative actors? Biomolecules. 2018;8(4):124.
59.REED LJ. A simple method of estimating fifty percent endpoints. Amjhyg. 1938;27.
60.Jiao X, Zhongqiong Y, Li L, Anchun C, Renyong J, Xu S, et al. Inhibitory Effect of Resveratrol against Duck Enteritis Virus In Vitro. PLoS One.8(6):e65213-.